Back

Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis - discussion

28 August 2026 (11:48 - 12:00)
Organised by: Logo
Congress Presentation Part of: Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis Imaging of Myocardial Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

4 More presentations in this session

Presentation thumbnail
Novel tracers to improve transthyretin amyloidosis diagnostics
Doctor S. Dorbala (Boston, US)
Slides Video
Presentation thumbnail
Imaging-guided risk stratification in transthyretin amyloidosis
Doctor K. Jering (Boston, US)
Slides Video
Presentation thumbnail
Therapy selection based on imaging
Professor M. Pieroni (Florence, IT)
Slides Video
Presentation thumbnail
Monitoring transthyretin amyloidosis diseases using imaging
Doctor M. Hundertmark (Bern, CH)
Slides Video

Access the full session

Session thumbnail
Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:48 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on translating cardiac amyloidosis imaging into precision diagnosis and prognostication
31 August 2026
thumbnail
Congress Presentation
Conclusions and panel/audience discussion
11 December 2024
thumbnail
Congress Presentation
Translating recent evidence into clinical practice for improved outcomes in ATTR-CM - Q&A
29 August 2026
thumbnail
Congress Presentation
Future perspectives: novel tracers, tracking disease progression, and response to therapy
11 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources